India urges BWC modernization
Analysis based on 10 articles · First reported Dec 01, 2025 · Last updated Dec 01, 2025
The event highlights the growing concern over bioterrorism and the need for robust biosecurity, which could drive investment and policy changes in the biotechnology and pharmaceutical sectors. India's prominent role and its significant contributions to global health, particularly in vaccine and generic medicine production, position it as a key player in future biosecurity initiatives, potentially boosting its related industries.
India's External Affairs Minister, S. Jaishankar, warned that the threat of biological weapons and bioterrorism is no longer theoretical, urging the international community to modernize global biosecurity frameworks under the Biological Weapons Convention (BWC). Speaking at a conference marking 50 years of the BWC, he highlighted the convention's structural inadequacies, including the lack of a compliance system, a permanent technical body, and a mechanism to track new scientific developments. S. Jaishankar reiterated India's support for stronger compliance and verification mechanisms and proposed a National Implementation Framework for biosecurity. He emphasized the importance of international cooperation, especially for the Global North and Global South, which is most vulnerable to biological threats. S. Jaishankar also showcased India's strong capacities in public health, pharmaceuticals, vaccines, and biosciences, positioning India as a trusted partner in global biosecurity efforts. The COVID-19 pandemic was cited as a critical learning experience underscoring the need for integrated public health and security systems.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard